(Q38170209)

English

BRAF inhibitors in cancer therapy.

scientific article published on 08 December 2013

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

title

BRAF inhibitors in cancer therapy (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

author

Carolina Hertzman Johansson

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

author name string

Suzanne Egyhazi Brage

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

publication date

8 December 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

published in

Pharmacology & Therapeutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

volume

142

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

page(s)

176-182

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

cites work

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE09626

Mutations of the BRAF gene in human cancer

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE00766

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2010.11.023

Identifiers

DOI

10.1016/J.PHARMTHERA.2013.11.011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 March 2020

PubMed publication ID

24325952

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24325952

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24325952%20AND%20SRC:MED&resulttype=core&format=json

(Q38170209)

BRAF inhibitors in cancer therapy.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)